- Condition: Influenza
Intervention: Other: Data collection
Sponsors: GlaxoSmithKline; GlaxoSmithKline; Sage Analytica
Not yet recruiting - verified May 2012 - Condition: Influenza (Pandemic)
Interventions: Biological: Monovalent Avian Influenza VLP (H5N1); Biological: Monovalent Avian Influenza VLP (H5N1); Biological: Monovalent Avian Influenza VLP (H5N1); Adjuvant; Biological: Monovalent Avian Influenza VLP (H5N1); Adjuvant; Biological: Monovalent Avian Influenza VLP (H5N1); Adjuvant; Biological: Saline Placebo
Sponsors: Novavax; Novavax; Department of Health and Human Services
Recruiting - verified May 2012 - Condition: Influenza, Human
Interventions: Drug: FluMist + Poly I:Poly C12U; Drug: FluMist + Poly I:Poly C12U; Drug: FluMist + Poly I:Poly C12U; Drug: FluMist + Poly I:Poly C12U; Drug: FluMist + Placebo
Sponsors: Hemispherx Biopharma; Hemispherx Biopharma
Recruiting - verified May 2012 - Condition: Influenza (Pandemic)
Interventions: Biological: Monovalent Avian Influenza VLP (H5N1); Biological: Monovalent Avian Influenza VLP (H5N1); Biological: Monovalent Avian Influenza VLP (H5N1); Adjuvant; Biological: Monovalent Avian Influenza VLP (H5N1); Adjuvant; Biological: Monovalent Avian Influenza VLP (H5N1); Adjuvant; Biological: Saline placebo
Sponsors: Novavax; Novavax; Department of Health and Human Services
Recruiting - verified May 2012 - Conditions: Influenza, Human; Orthomyxoviridae Infections; RNA Virus Infections; Virus Diseases; Respiratory Tract Infections; Respiratory Tract Diseases
Intervention: Biological: FVH1 - a DNA-based influenza vaccine
Sponsors: University of Manitoba; University of Manitoba; Inovio Pharmaceuticals
Not yet recruiting - verified May 2012 - Condition: Influenza
Intervention:
Sponsors: University of Alberta; University of Alberta
Not yet recruiting - verified April 2012 - Condition: Influenza
Intervention: Biological: 2012 trivalent influenza vaccine
Sponsors: University of Sao Paulo General Hospital; University of Sao Paulo General Hospital; D'Antonio Consultants International; Butantan Institute; Sao Paulo, Secretaria de Estado da Saúde
Not yet recruiting - verified April 2012 - Conditions: Meningitis; Influenza
Interventions: Biological: A+C+hib Conjugate Vaccine; Biological: Placebo; Biological: A+C Vaccine; Biological: Hib vaccine
Sponsors: Jiangsu Province Centers for Disease Control and Prevention; Jiangsu Province Centers for Disease Control and Prevention; Royal (Wuxi) Biological Co., LTD
Recruiting - verified April 2012 - Condition: Influenza
Interventions: Biological: Trivalent Influenza Virus Vaccine; Other: Placebo
Sponsors: MedImmune LLC; MedImmune LLC; AstraZeneca, PLC
Not yet recruiting - verified April 2012 - Conditions: Pregnancy; Investigation or Care in A Nonpregnant Woman
Intervention: Biological: Seasonal influenza vaccination
Sponsors: Instituto Nacional de Salud Publica, Mexico; Instituto Nacional de Salud Publica, Mexico; Laboratorios de Biologicos y Reactivos de México, S.A. de C.V.
Not yet recruiting - verified April 2012 - Condition: Influenza
Interventions: Biological: H5N1 Vaccine; Drug: ASO3 Adjuvant
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - verified March 2012 - Conditions: Haemophilus Influenzae Type b Diseases; Diphtheria; Poliomyelitis; Pertussis; Tetanus
Intervention: Biological: Infanrix-IPV+HibTM
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Not yet recruiting - verified April 2012 - Conditions: Influenza; Healthy
Interventions: Biological: H5N1 vaccine plus MF59 adjuvant; Biological: H5N1 vaccine without adjuvant
Sponsors: National Institutes of Health Clinical Center (CC); National Heart, Lung, and Blood Institute (NHLBI); Center for Human Immunology, Autoimmunity and Inflammation
Recruiting - verified February 2012 - Condition: Influenza Virus
Interventions: Drug: VX-787; Drug: VX-787
Sponsors: Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals Incorporated
Not yet recruiting - verified March 2012 - Condition: Influenza
Interventions: Biological: Influenza Virus Vaccine(no Preservative ); Biological: Influenza Virus Vaccine(contains Preservative)
Sponsors: Chinese Academy of Medical Sciences; Chinese Academy of Medical Sciences; Hebei province Center for Disease Prevention and Control; National Institute for the Control of Pharmaceutical and Biological Products, China
Recruiting - verified March 2012 - Condition: Influenza
Interventions: Biological: Influenza Virus Vaccine (no Preservative ); Biological: Influenza Virus Vaccine(contains Preservative)
Sponsors: Chinese Academy of Medical Sciences; Chinese Academy of Medical Sciences; Hebei province Center for Disease Prevention and Control; National Institute for the Control of Pharmaceutical and Biological Products, China
Recruiting - verified March 2012 - Condition: Influenza
Intervention: Drug: Oseltamivir
Sponsors: University of Oxford; University of Oxford
Not yet recruiting - verified March 2012 - Condition: Influenza A Virus Infection
Intervention: Drug: Gutron® treatment
Sponsors: Hospices Civils de Lyon; Hospices Civils de Lyon
Recruiting - verified March 2012 - Conditions: Neisseria Meningitidis; Bacterial Infections; Virus Diseases
Interventions: Biological: V419 (PR5I); Biological: Prevenar 13; Biological: NeisVac-C; Biological: MENJUGATE; Biological: MENITORIX; Biological: M-M-RVAXPRO
Sponsors: Sanofi Pasteur MSD; Sanofi Pasteur MSD
Recruiting - verified May 2012 - Condition: Influenza
Interventions: Biological: Intradermal vaccine; Biological: Intramuscular vaccine
Sponsors: Centers for Disease Control and Prevention; Centers for Disease Control and Prevention; Ministry of Health, Thailand
Recruiting - verified February 2012 - Condition: Influenza
Intervention: Biological: VAX161 [STF2.HA5 H5N1]
Sponsors: VaxInnate Corporation; VaxInnate Corporation
Not yet recruiting - verified March 2012 - Condition: Influenza A Subtype H7N7 Infection
Intervention: Biological: Monovalent Influenza Subvirion Vaccine, H7N7
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - verified February 2012 - Conditions: Flu; Cold; Respiratory Tract Allergies
Interventions: Drug: naphazoline hydrocloride; Drug: Naphazoline hydrocloride + Pheniramine Maleate + Panthenol
Sponsors: EMS; EMS
Not yet recruiting - verified November 2011 - Condition: Influenza
Intervention: Biological: AdimFlu-S Influenza Vaccine
Sponsors: Adimmune Corporation; Adimmune Corporation
Recruiting - verified January 2012 - Condition: Influenza
Intervention:
Sponsors: Dalhousie University; Dalhousie University; Public Health Agency of Canada (PHAC); Canadian Institutes of Health Research (CIHR); GlaxoSmithKline
Recruiting - verified January 2012 - Condition: Healthy Free-living Elderly
Interventions: Other: 1-Fermented Dairy Product (test); Other: 2-Milk-based non-fermented dairy product (control)
Sponsors: Danone Research; Danone Research
Recruiting - verified January 2012 - Condition: Chronic Illness
Interventions: Biological: influenza vaccine; Drug: Imiquimod; Biological: influenza vaccine; Drug: Aqueous cream; Biological: influenza vaccine; Drug: Aqueous cream
Sponsors: The University of Hong Kong; The University of Hong Kong
Recruiting - verified January 2012 - Condition: Influenza
Interventions: Biological: IVACFLU; Other: PBS (Phosphate buffered saline)
Sponsors: Program for Appropriate Technology in Health; Program for Appropriate Technology in Health; Institute of Vaccines and Medical Biologicals, Nha Trang; Pasteur Institute, Ho Chi Minh City
Not yet recruiting - verified January 2012 - Conditions: Influenza; Avian Influenza
Interventions: Biological: live attenuated monovalent A/17/mallard/Netherlands/00/95(H7N3) influenza vaccine; Biological: placebo
Sponsors: Program for Appropriate Technology in Health; Program for Appropriate Technology in Health; Russia: Microgen Scientific Industrial Company for Immunobiological Medicines; Russia: Research Institute of Influenza; Russia: Institute of Experimental Medicine
Not yet recruiting - verified January 2012 - Conditions: Cough; Myalgia; Nasal Obstruction; Sore Throat; Headache; Fatigue; Fever
Intervention:
Sponsors: Cellex, Inc.; Cellex, Inc.; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified January 2012 - Condition: Influenza
Interventions: Biological: Trivalent influenza vaccine (seasonal); Biological: Normal saline
Sponsors: University of Witwatersrand, South Africa; University of Witwatersrand, South Africa
Not yet recruiting - verified April 2012 - Condition: Influenza, Human
Intervention: Drug: 600mg intravenous (IV) zanamivir
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Recruiting - verified February 2012 - Condition: Atopic Dermatitis
Intervention: Drug: Fluzone® Intradermal (Sanofi Pasteur Inc.)
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified December 2011 - Condition: Healthy
Interventions: Biological: Influenza vaccine; Biological: Influenza vaccine
Sponsors: International Vaccine Institute; International Vaccine Institute
Recruiting - verified December 2011 - Conditions: Pregnancy; Influenza
Intervention:
Sponsors: University of Utah; University of Utah
Recruiting - verified April 2012 - Condition: Influenza
Intervention: Behavioral: Influenza vaccination implementation strategy
Sponsors: University Medical Centre Groningen; University Medical Centre Groningen; ZonMw: The Netherlands Organisation for Health Research and Development
Recruiting - verified December 2011 - Conditions: Bacterial Infections; Virus Diseases
Interventions: Biological: V419; Biological: Rotavirus vaccine; Biological: Prevenar 13; Biological: INFANRIX hexa
Sponsors: Sanofi Pasteur MSD; Sanofi Pasteur MSD; Merck
Recruiting - verified May 2012 - Condition: Fever
Intervention:
Sponsors: Columbia University; Columbia University; Centers for Disease Control and Prevention
Recruiting - verified November 2011 - Condition: Influenza
Intervention: Drug: AdimFlu-S
Sponsors: National Cheng-Kung University Hospital; National Cheng-Kung University Hospital
Recruiting - verified January 2012 - Condition: Fibromyalgia Syndrome
Interventions: Biological: Inactivated split virion Influenza vaccine; Biological: WHO recommended 2011 Influenza vacccine
Sponsors: Tel-Aviv Sourasky Medical Center; Tel-Aviv Sourasky Medical Center
Not yet recruiting - verified October 2011 - Efficacy and Safety of Inhaled Zanamivir in Treatment of Influenza A and B Virus Infections in ChinaConditions: Influenza A Virus Infection; Influenza B Virus Infection
Interventions: Drug: Zanamivir; Drug: Placebo
Sponsors: Jiangsu Simcere Pharmaceutical R&D Co. Ltd.; Jiangsu Simcere Pharmaceutical R&D Co. Ltd.
Recruiting - verified November 2011 - Condition: Influenza
Interventions: Biological: MVA-NP+M1 and seasonal Influenza vaccine; Biological: Saline placebo and seasonal influenza vaccine
Sponsors: University of Oxford; University of Oxford
Recruiting - verified November 2011 - Condition: Influenza
Intervention: Biological: Inflexal V
Sponsors: Crucell Holland BV; Crucell Holland BV
Recruiting - verified October 2011 - Condition: Central Nervous System Neoplasm
Interventions: Biological: trivalent influenza vaccine; Other: laboratory biomarker analysis
Sponsors: Comprehensive Cancer Center of Wake Forest University; Comprehensive Cancer Center of Wake Forest University; National Cancer Institute (NCI)
Recruiting - verified November 2011 - Conditions: Poliomyelitis; Haemophilus Influenzae Type b Disease; Hepatitis B; Diphtheria; Pertussis; Tetanus
Interventions: Biological: Combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus and Haemophilus influenzae type b vaccine (GSK217744) - Formulation A; Biological: Combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus and Haemophilus influenzae type b vaccine (GSK217744) - Formulation B; Biological: Infanrix hexaTM; Biological: Pfizer's 13-valent pneumococcal polysaccharide conjugate vaccine (Prevenar 13®)
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Recruiting - verified February 2012 - Conditions: Upper Respiratory Tract Infection; Nasal Congestion; Rhinorrhea; Sneezing
Interventions: Drug: Paracetamol (500 mg)/dimethindene maleate (1 mg)/ phenylephrine hydrochloride (10 mg) tablets; Drug: Paracetamol (500 mg) tablets
Sponsors: Novartis; Novartis; NOVARTIS BIOCIÊNCIAS S.A.
Not yet recruiting - verified April 2012 - Condition: H5N1 Influenza
Interventions: Biological: Ad4-H5-VTN vaccination-tonsillar route; Biological: Ad4-H5-vaccination-oral route
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified September 2011 - Condition: H5N1 Influenza
Intervention: Biological: H5N1 Vaccine
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified October 2011 - Condition: Flu
Interventions: Behavioral: Easy list of healthy habits; Behavioral: Challenging list of healthy habits; Behavioral: Control
Sponsors: University of Pennsylvania; University of Pennsylvania
Not yet recruiting - verified October 2011 - Condition: Influenza
Interventions: Biological: 2011-2012 Sanofi Pasteur Fluzone®; Biological: 2011-2012 Sanofi Pasteur Fluzone® High Dose
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified November 2011 - Condition: Parainfluenza Infection
Interventions: Drug: DAS181; Other: Placebo
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified March 2012 - Conditions: Influenza; Influenza Like Illness; Severe Acute Respiratory Illness
Intervention: Biological: Seasonal influenza vaccine
Sponsors: Centers for Disease Control and Prevention; Centers for Disease Control and Prevention; Kenya Ministry of Health; Kenya Medical Research Institute; Sanofi Pasteur MSD
Recruiting - verified September 2011 - Condition: Influenza
Intervention: Device: Respirio Flu Test
Sponsors: Respirio Pty Ltd; Respirio Pty Ltd
Recruiting - verified September 2011 - Condition: Influenza
Interventions: Biological: Inactivated Influenza Vaccine Trivalent Types A and B; Biological: Meningococcal Polysaccharide-Diphtheria Toxoid Conjugate Vaccine
Sponsors: University of Maryland; University of Maryland; Bill and Melinda Gates Foundation
Not yet recruiting - verified September 2011 - Conditions: Glucose Intolerance; Pregnancy
Intervention: Drug: Probiotics Lactobacillus Rhamnosus
Sponsors: Aga Khan University; Aga Khan University
Not yet recruiting - verified September 2011 - Conditions: Respiratory Tract Infections; Bronchiolitis Obliterans; Cryptogenic Organizing Pneumonia; Lung Diseases, Interstitial
Interventions: Drug: Prednisone; Drug: Azithromycin; Drug: Montelukast; Drug: Symbicort
Sponsors: Maisonneuve-Rosemont Hospital; Maisonneuve-Rosemont Hospital; The Canadian Blood and Marrow Transplant Group
Recruiting - verified January 2012 - Condition: Influenza
Intervention:
Sponsors: Fraser Health; Fraser Health; Novartis Pharmaceuticals
Not yet recruiting - verified August 2011 - Conditions: Duchenne Muscular Dystrophy; Spinal Muscular Atrophy; Congenital Muscular Dystrophy
Interventions: Biological: 2011-2012 seasonal flu vaccine; Biological: 2011-2012 seasonal flu vaccine
Sponsors: Children's Hospital Medical Center, Cincinnati; Children's Hospital Medical Center, Cincinnati
Recruiting - verified August 2011 - Conditions: Influenza; Healthy
Interventions: Biological: Multimeric-001; Biological: Multimeric-001, 500 mcg; Biological: Multimeric-001, 500mcg; Biological: Saline and TIV
Sponsors: BiondVax Pharmaceuticals ltd.; BiondVax Pharmaceuticals ltd.
Recruiting - verified August 2011 - Condition: Influenza-like Illness
Intervention:
Sponsors: Mexican Infectious Disease Network; Mexican Infectious Disease Network; National Institute of Allergy and Infectious Diseases (NIAID); Secretaria de Salud, Mexico; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran; Instituto Nacional de Enfermedades Respiratorias; National Institute of Pediatrics, Mexico; Hospital General Dr. Manuel Gea González; Hospital Infantil de Mexico Federico Gomez
Recruiting - verified August 2011 - Condition: Distal Radius Fractures
Interventions: Procedure: Kirschner wire fixation; Procedure: Volar Locking Plate fixation
Sponsors: University of Warwick; University of Warwick; University Hospitals Coventry and Warwickshire NHS Trust; DePuy International
Recruiting - verified September 2011 - Condition: Orthostatic Hypotension
Intervention: Other: Hand grip maneuver
Sponsors: Tel-Aviv Sourasky Medical Center; Tel-Aviv Sourasky Medical Center
Not yet recruiting - verified January 2012 - Conditions: Argininosuccinic Aciduria; Carbamoyl-Phosphate Synthase I Deficiency; Citrullinemia; Ornithine Carbamoyltransferase Deficiency; Hyperargininemia; N-Acetylglutamate Synthase Deficiency
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Human Genome Research Institute (NHGRI)
Recruiting - verified July 2011 - Condition: Influenza
Interventions: Biological: non-elderly aged between 18 and 60; Biological: elderly aged over 60
Sponsors: Adimmune Corporation; Adimmune Corporation
Not yet recruiting - verified August 2011 - Condition: Healthy
Interventions: Biological: INO-3605; Biological: INO-3609; Biological: INO-3401; Biological: INO-3609; Biological: INO-3605 AND INO-3609; Biological: INO-3510; Biological: INO-3609; Biological: INO-3609; Biological: Seasonal Influenza vaccine; Biological: INO-3609
Sponsors: Inovio Pharmaceuticals; Inovio Pharmaceuticals
Recruiting - verified November 2011 - Condition: Acute Myeloid Leukaemia
Intervention: Drug: Cytarabine
Sponsors: University of Leipzig; University of Leipzig
Recruiting - verified April 2008 - Condition: Haemophilus Influenzae Type B Infection
Intervention: Biological: Haemophilus influenza type b conjugate vaccine
Sponsors: Novartis; Novartis Vaccines
Recruiting - verified February 2012 - Conditions: Influenza; Collaboration
Interventions: Behavioral: Private/public collaborative efforts to increase flu vaccination; Behavioral: Usual care
Sponsors: University of Colorado, Denver; University of Colorado, Denver; Centers for Disease Control and Prevention
Recruiting - verified July 2011 - Condition: Narcolepsy
Intervention: Other: No intervention
Sponsors: Hopital du Sacre-Coeur de Montreal; Hopital du Sacre-Coeur de Montreal; GlaxoSmithKline
Recruiting - verified July 2011 - Condition: Influenza Caused by Unspecified Influenza Virus
Intervention: Device: Electrosensing antibody probing system (e- Ab sensor)
Sponsors: National Taiwan University Hospital; National Taiwan University Hospital
Recruiting - verified May 2011 - Condition: Influenza, Human
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified April 2012 - Conditions: Acute Myeloid Leukemia; Myelodysplastic Syndrome
Intervention: Drug: Decitabine plus Fludarabine and Busulfan
Sponsors: Hackensack University Medical Center; Hackensack University Medical Center
Recruiting - verified October 2011 - Conditions: Diphtheria; Hepatitis B; Haemophilus Influenzae Type b Disease; Poliomyelitis; Pertussis; Tetanus
Intervention: Biological: Infanrix hexa™
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Not yet recruiting - verified April 2012 - Condition: Clinically Suspected H1N1 Infection
Intervention:
Sponsors: Medical University of Graz; Medical University of Graz
Recruiting - verified November 2011 - Condition: Flu-like Symptoms
Intervention:
Sponsors: Baylor College of Medicine; Christine Hunter; Merz Pharmaceuticals, LLC
Recruiting - verified February 2012 - Condition: Influenza, Human
Interventions: Drug: Oseltamivir; Drug: Oseltamivir Placebo
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified April 2012 - Condition: Influenza
Interventions: Biological: Trivalent influenza vaccine; Biological: Normal saline
Sponsors: University of Witwatersrand, South Africa; University of Witwatersrand, South Africa; Emory University; University of Colorado, Denver; Bill and Melinda Gates Foundation
Recruiting - verified November 2011 - Conditions: Immunological Stimulation; Attenuated Vaccine
Intervention: Biological: BMB72 (actA/plcB-deleted Listeria monocytogenes expressing influenza A nucleoprotein)
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital
Recruiting - verified February 2012 - Conditions: A/H1N1 Influenza; Swine Flu
Intervention:
Sponsors: St. Jude Children's Research Hospital; St. Jude Children's Research Hospital; American University of Beirut Medical Center
Recruiting - verified May 2012 - Condition: Immune Response
Intervention: Procedure: Blood sample
Sponsors: Hospices Civils de Lyon; Hospices Civils de Lyon
Recruiting - verified December 2011 - A Study to Identify and Characterise Bacteria Causing Chronic Cough Among Children in United KingdomCondition: Chronic Cough
Interventions: Procedure: Cough swab; Procedure: Oropharyngeal swab; Procedure: Nasopharyngeal swabs; Procedure: Blood sample; Procedure: Bronchoscopy/ bronchoalveolar lavage samples; Other: Data collection
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Not yet recruiting - verified May 2012 - Condition: Breast Cancer
Interventions: Genetic: polymorphism analysis; Other: laboratory biomarker analysis; Procedure: quality-of-life assessment
Sponsors: International Breast Cancer Study Group; International Breast Cancer Study Group
Recruiting - verified March 2012 - Conditions: Influenza; Pneumonia, Viral; Pulmonary Fibrosis; Quality of Life; Stress Disorders, Post Traumatic
Intervention:
Sponsors: Institut National de la Santé Et de la Recherche Médicale, France; Institut National de la Santé Et de la Recherche Médicale, France
Recruiting - verified January 2012 - Condition: Influenza, Human
Interventions: Biological: GHB16L2; Biological: Placebo
Sponsors: AVIR Green Hills Biotechnology AG; AVIR Green Hills Biotechnology AG
Recruiting - verified August 2011 - Condition: Egg Allergy
Intervention: Biological: Trivalent Influenza Vaccine
Sponsors: University of Michigan Health System; University of Michigan Health System; American College of Allergy, Asthma and Immunology
Recruiting - verified October 2011 - Condition: Smoking
Interventions: Dietary Supplement: Broccoli sprout homogenate; Dietary Supplement: Alfalfa sprout homogenate
Sponsors: University of North Carolina, Chapel Hill; University of North Carolina, Chapel Hill; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified February 2012 - Condition: Influenza Infection in Transplant Patients
Intervention:
Sponsors: University of Alberta; University of Alberta
Recruiting - verified April 2012 - Conditions: Pneumococcal Disease; Haemophilus Influenzae Infections
Interventions: Biological: Pneumococcal vaccine GSK2189242A (formulation 1); Other: Pneumococcal vaccine GSK2189242A (formulation 2); Biological: SynflorixTM; Biological: Prevenar 13TM; Biological: TritanrixTM-HepB/Hib; Biological: Polio SabinTM; Biological: M-VacTM; Biological: StamarilTM
Sponsors: GlaxoSmithKline; GlaxoSmithKline; Program for Appropriate Technology in Health; Department of State for Health and Social Welfare, The Gambia; Medical Research Council Laboratories, Gambia; London School of Hygiene and Tropical Medicine
Recruiting - verified December 2011 - Conditions: Influenza; Respiratory Syncytial Viruses; Paramyxoviridae Infections; Coronavirus; Rhinovirus
Interventions: Device: N95 Respirator; Device: Medical/surgical mask
Sponsors: Johns Hopkins University; Johns Hopkins University; Centers for Disease Control and Prevention; Department of Veterans Affairs; National Institute for Occupational Safety and Health (NIOSH/CDC)
Recruiting - verified March 2012 - Conditions: Influenza A Virus, H1N1 Subtype; Influenza, Human; Influenza B Virus; Influenza, Seasonal
Interventions: Drug: 300mg intravenous (IV) zanamivir and oral oseltamivir placebo; Drug: 600mg intravenous (IV) zanamivir and oral oseltamivir placebo; Drug: 75mg oral oseltamivir and intravenous zanamivir placebo
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Recruiting - verified May 2012 - Condition: Vaccine Safety
Intervention: Other: Text message surveillance
Sponsors: Columbia University; Columbia University; Centers for Disease Control and Prevention
Recruiting - verified November 2011 - Condition: Influenza
Interventions: Drug: Amantadine, Ribavirin, Oseltamivir; Drug: Oseltamivir
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified April 2012 - Condition: Influenza Infection
Intervention: Dietary Supplement: green tea
Sponsors: University of Shizuoka; University of Shizuoka
Recruiting - verified February 2011 - Condition: Influenza (Seasonal)
Interventions: Biological: Novartis MF59-adjuvanted influenza subunit vaccine; Biological: Sandoz Korea MF59-adjuvanted influenza subunit vaccine
Sponsors: Novartis; Novartis Vaccines
Recruiting - verified January 2012 - Condition: Influenza
Interventions: Behavioral: Intervention Group; Behavioral: Control Group
Sponsors: Ottawa Hospital Research Institute; Ottawa Hospital Research Institute; Élisabeth Bruyère Research Institute; Canadian Center for Vaccinology
Recruiting - verified July 2011 - Conditions: HIV; Cancer
Intervention: Biological: Fluzone High Dose Vaccine Vs Fluzone
Sponsors: St. Jude Children's Research Hospital; St. Jude Children's Research Hospital
Recruiting - verified April 2012 - Condition: H1N1 Influenza Treatment During Pregnancy
Intervention:
Sponsors: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified February 2012 - Condition: Influenza
Interventions: Biological: seasonal influenza vaccine; Biological: seasonal influenza vaccine; Biological: seasonal influenza vaccine
Sponsors: Queen Saovabha Memorial Institute; Queen Saovabha Memorial Institute
Recruiting - verified July 2011 - Condition: Influenza Infection
Interventions: Biological: Live attenuated influenza vaccine; Biological: Inactivated influenza vaccine
Sponsors: University of Rochester; University of Rochester
Recruiting - verified August 2011 - Condition: Influenza
Interventions: Biological: Inactivated Trivalent Influenza Vaccine; Biological: Live Attenuated Influenza Vaccine; Drug: Placebo (IN); Drug: Placebo (IM)
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified November 2011 - Condition: Influenza
Interventions: Drug: DAS181; Drug: Placebo
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified March 2012 - Conditions: Patient Compliance; Medication Adherence; Medication Non-Adherence
Intervention: Behavioral: Information prescriptions
Sponsors: Johns Hopkins University; Johns Hopkins University; National Library of Medicine (NLM)
Recruiting - verified June 2011 - Condition: Influenza
Intervention: Biological: Trivalent Inactivated Influenza Vaccine
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified January 2012 - Conditions: Refractory Multiple Myeloma; Stage I Multiple Myeloma; Stage II Multiple Myeloma
Interventions: Drug: bortezomib; Drug: fludarabine phosphate; Other: melphalan; Radiation: intensity-modulated radiation therapy; Radiation: total marrow irradiation; Radiation: tomotherapy; Drug: tacrolimus; Drug: sirolimus
Sponsors: City of Hope Medical Center; City of Hope Medical Center
Recruiting - verified March 2012 - Condition: Avian Influenza
Intervention:
Sponsors: St. Jude Children's Research Hospital; St. Jude Children's Research Hospital; National Institutes of Health (NIH)
Recruiting - verified December 2011 - Condition: Influenza
Intervention: Other: Provider Alert
Sponsors: Columbia University; Columbia University; Agency for Healthcare Research and Quality (AHRQ)
Recruiting - verified November 2011 - Condition: Influenza A Virus Infection
Interventions: Drug: Interferon-alpha; Drug: Oseltamivir; Other: maltose lozenge
Sponsors: Amarillo Biosciences, Inc.; Amarillo Biosciences, Inc.; CytoPharm, Inc.
Recruiting - verified January 2012 - Condition: Influenza
Interventions: Other: Text Message; Other: automated call
Sponsors: Columbia University; Columbia University
Recruiting - verified November 2011 - Conditions: Influenza; (Influenza A and Subtypes Such as H3N2 and 2009 H1N1 or Influenza B)
Intervention:
Sponsors: University of Minnesota - Clinical and Translational Science Institute; University of Minnesota - Clinical and Translational Science Institute; National Institute of Allergy and Infectious Diseases (NIAID); National Institutes of Health (NIH)
Recruiting - verified April 2012 - Condition: Influenza
Intervention:
Sponsors: University of Minnesota - Clinical and Translational Science Institute; University of Minnesota - Clinical and Translational Science Institute; National Institute of Allergy and Infectious Diseases (NIAID); National Institutes of Health (NIH)
Recruiting - verified April 2012 - Condition: Influenza
Intervention: Drug: Tamiflu
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified May 2012 - Condition: Influenza A
Interventions: Biological: Anti-Influenza Plasma; Behavioral: Standard Care
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified May 2012 - Condition: Influenza
Interventions: Drug: Tamiflu; Drug: Tamiflu
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified May 2012 - Condition: Influenza Human
Interventions: Biological: influenza vaccine; Biological: saline placebo
Sponsors: Children's Hospital Medical Center, Cincinnati; Children's Hospital Medical Center, Cincinnati; Bill and Melinda Gates Foundation; Seattle Children's Hospital; Tribhuvan University, Nepal; Johns Hopkins Bloomberg School of Public Health
Recruiting - verified February 2012 - Condition: Influenza
Intervention: Drug: oseltamivir [Tamiflu]
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified May 2012 - Condition: Influenza
Intervention:
Sponsors: Uniformed Services University of the Health Sciences; Uniformed Services University of the Health Sciences; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified April 2012 - Conditions: Herpesvirus; Adenovirus; Cytomegalovirus; Human Papillomavirus; Human Polyomavirus; Influenza Virus; Rhinovirus; Coronavirus; Respiratory Syncytial Virus
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified August 2011 - Condition: Influenza Virus
Intervention:
Sponsors: St. Jude Children's Research Hospital; St. Jude Children's Research Hospital
Recruiting - verified May 2012 - Condition: Influenza
Intervention: Drug: Tamiflu
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Not yet recruiting - verified May 2012 - Conditions: Cough; Sore Throat; Nasal Congestion; Headache; Fever; Seasonal Influenza
Interventions: Drug: Peramivir 600mg Adults, Peramivir 10mg/kg Adolescents; Drug: Placebo Peramivir
Sponsors: BioCryst Pharmaceuticals; BioCryst Pharmaceuticals; Department of Health and Human Services
Recruiting - verified March 2012 - Condition: Influenza
Interventions: Biological: MVA-NP+M1; Biological: MVA-NP+M1; Biological: MVA-NP+M1
Sponsors: University of Oxford; University of Oxford; Wellcome Trust
Recruiting - verified June 2011 - Condition: Influenza A
Intervention: Biological: Influenza A vaccine
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID); National Institutes of Health (NIH)
Recruiting - verified August 2011 - Condition: Immune Response
Interventions: Biological: Fluvirin; Biological: Flulaval; Biological: Fluzone; Biological: Fluarix; Biological: Afluria
Sponsors: University of Massachusetts, Worcester; University of Massachusetts, Worcester
Recruiting - verified March 2012 - Condition: Influenza
Intervention: Procedure: Virology testing
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified December 2011 - Condition: Aplastic Anemia
Intervention: Drug: Cyclophosphamide, Fludarabine, Thymoglobulin
Sponsors: The Korean Society of Pediatric Hematology Oncology; The Korean Society of Pediatric Hematology Oncology
Recruiting - verified March 2012 - Conditions: Haemophilus Infections; Diphtheria; Tetanus; Polio; Pertussis
Intervention: Biological: DTaP-IPV/Hib
Sponsors: Sanofi-Aventis; Sanofi-Aventis
Recruiting - verified January 2012 - Conditions: Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae
Interventions: Biological: DTaP-IPV/Hib; Biological: Other DTap Vaccines
Sponsors: Sanofi-Aventis; Sanofi-Aventis
Recruiting - verified April 2012 - Conditions: Influenza Type A; Influenza Type B
Intervention: Procedure: Nasopharyngeal Swab
Sponsors: St. Jude Children's Research Hospital; St. Jude Children's Research Hospital; The University of Hong Kong
Recruiting - verified November 2011 - Conditions: Poliomyelitis; Haemophilus Influenzae Type b Disease; Hepatitis B; Diphtheria; Pertussis; Tetanus
Intervention: Biological: Infanrix™ hexa
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Recruiting - verified August 2011 - Condition: Osteoarthritis, Carpometacarpal
Interventions: Device: Comfort Cool thumb splint by North Coast Medical; Device: Custom made thermoplastic & neoprene splint
Sponsors: University of British Columbia; University of British Columbia; Vancouver Foundation
Recruiting - verified April 2012 - Condition: Influenza
Interventions: Drug: oseltamivir; Drug: oseltamivir; Other: Alternative Control
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified May 2012 - Conditions: Influenza, Human; Immunocompromised Host
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified May 2012 - Conditions: Mycobacterium Infections, Atypical; Granulomatous Disease, Chronic; Job's Syndrome; Influenza, Human
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified September 2011 - Condition: DeQuervain's Tenosynovitis
Intervention:
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital
Recruiting - verified March 2012
 |
Join Clinical Trials for Influenza |
